1,3,5-Tri-O-Benzoyl-Alpha-D-Ribofuranose CAS NO.22224-41-5

Micro-mega Industry ,based on the research and development and innovation driven, is committed to provide best quality and professional service to meet customer's requirement. We are operating one R&D center, one mid-pilot workshop and one chemicals intermediates factory.

In the pharmaceutical industry, we focus on the following three areas of the drugs:

1 The Ribose and Nucleoside Derivatives in the field of anti-Cancer and anti-Viral drugs

2 The Nervous System Disease drugs

3 The Hypertension, Diabetes drugs

It is one of key strategies of Micro-mega to improve our core competition ability by strengthening the independent innovation capability and continuous investment. We have the ability to accept the CRO and CMO business and wish to cooperate with all customers and grow together.